Scripps Translational Science Institute

company

About

Scripps Translational Science Institute works to translate the latest advances in genomics into new diagnostics and treatments.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$34M
Industries
Biotechnology,Genetics,Health Care
Founded date
Jan 1, 2006
Number Of Employee
11 - 50
Operating Status
Active

Scripps Translational Science Institute works to translate the latest advances in genomics into new diagnostics and treatments.

In collaboration with Scripps Genomic Medicine, STSI researchers have collected DNA to generate a comprehensive human DNA bank. These samples could help identify genetic markers for cardiovascular disease, breast, colon and prostate cancers. and other conditions.

STSI and Scripps Genomic Medicine investigators have also partnered with Affymetrix, Microsoft, and Navigenics to determine whether personal genomic testing motivates people to make positive lifestyle changes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$34M
Scripps Translational Science Institute has raised a total of $34M in funding over 2 rounds. Their latest funding was raised on May 2, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 2, 2018 Grant $34M 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Scripps Translational Science Institute is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant